US IVD (In Vitro Diagnostic) growth set to continue despite cost constraints
This article was originally published in Clinica
US demand for in vitro diagnostic (IVD) reagents and instrumentation will continue to grow at 6% a year to reach $10.5 billion by 2003. Cost-containment pressures will continue to force prices down and constrain demand, but this will be more than offset by the growth of the point-of-care and home testing markets. These are the conclusions of the Freedonia Group, a US industrial market research company.